Att empting to produce cyclized systems with potential anti-proliferative activity, a series of novel thiophene and benzothiophene derivatives were designed and synthesized. The reactivity of the latt er derivatives towards diff erent chemical reagents was studied. Twenty-one compounds were synthesized and evaluated as anti-cancer agents. The results showed that ethyl 5-amino-3-(4-chlorostyryl)-4-cyanothiophene-2-carboxylate (5b), ethyl 5-amino-4-((4-methoxyphenyl)carbonyl)-3-methylhiophene-2-carboxylate (8c) and 5-3-(ethoxy-3-oxopropanamido)-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxylate (9) were the most active compounds towards three tumor cell lines -MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and SF-268 (CNS cancer) and a normal fi broblast human cell line (WI-38) compared to the anti-proliferative eff ects of the reference control doxorubicin.
Ethyl 5-(acetylamino)-4-cyano-3-methylthiophene-2-carboxylate
. -A solution of 1a (2.10 g, 0.01 mol) in acetic acid/acetic anhydride (10:3 mL) was heated under refl ux for 3 hours. The solid product formed upon pouring into an ice/water mixture was collected by fi ltration, washed with water and crystallized from ethanol to give 2 (Table I) . , 5 mL) under continuous stirring] was gradually added under stirring. The solid products formed upon cooling in an ice bath were collected by fi ltration, washed with water and crystallized from ethanol to give 3a-d, respectively (Table I) . (4) . -To a mixture of 1a (2.10 g, 0.01 mol) and ethyl orthoformate (1.48 g, 0.01 mol), a catalytic amount of piperidine was added and the reaction mixture was heated in an oil bath at 120 °C for 2 hours. The mixture was then boiled in ethanol for a few minutes, poured onto an acidifi ed ice/water mixture and the product was crystallized from ethanol to give 4 (Table I) . (6) . General procedure. -To a solution of 1a (2.10 g, 0.01 mol) containing a catalytic amount of piperidine (0.5 mL), either benzaldehyde (1.06 g, 0.01 mol), 4-chlorobenzaldehyde (1.40 g, 0.01 mol), 4-methoxybenzaldehyde (1.36 g, 0.01 mol) or salicyaldehyde (1.22 g, 0.01 mol) was added and heated in an oil bath at 120 o C for about 2 hours, then boiled in ethanol (20 mL) for a few minutes. The solid products obtained upon pouring into an acidifi ed ice/water mixture were crystallized from ethanol to give 5a-c and 6, respectively (Table I) .
Ethyl 5-amino-4-cyano-3-((2-phenylhydrazinylidene)methyl) thiophene-2-carboxylate (3a), ethyl 5-amino-3-(2-(4-chlorophenyl)hydrazinylidene)-methyl-4-cyanothiophene-2-carboxylate (3b), ethyl 5-amino-4-cyano-3-[2-(4-methoxyphenyl)hydrazinylidene]-methyl thiophene-2-carboxylate (3c) and ethyl 5-amino-4-cyano-3-(2-(4-methylphenyl)hydrazinylidene)methylthiophene-2-carboxylate (3d)
.
Ethyl 4-cyano-5-((2,2-dicyanoethylidene)amino)-3-methylthiophene-2-carboxylate
Ethyl 5-amino-4-cyano-3-styrylthiophene-2-carboxylate (5a), ethyl 5-amino-3-(4-chlorostyryl)- 4-cyanothiophene-2-carboxylate (5b), ethyl 5-amino-4-cyano-3-[2-(2-methoxyphenyl)-ethenyl]thio- phene-2-carboxylate (5c) and ethyl 5-amino-4-cyano-3-[2-(2-hydroxypentyl)ethenyl]thiophene-car- boxylate
Ethyl 3,6-diamino-5-cyano-4-hydroxybenzo[c]thiophene-1-carboxylate (7)
. -To a solution of 1b (2.57 g, 0.01 mol) in 1,4-dioxane (25 mL) containing a catalytic amount of triethylamine, malononitrile (0.66 g, 0.01 mol) was added. The reaction mixture was heated under refl ux for 3 hours, then cooled and neutralized by pouring into an ice/water mixture containing a few drops of hydrochloric acid. The solid product formed was collected by fi ltration and crystallized from 1,4-dioxane to give 7 (Table I) . 01 mol) and elemental sulfur (0.32 g, 0.01 moL) were added. The reaction mixture was heated under refl ux for 5 hours, then cooled, and neutralized by pouring into an acidifi ed ice/water mixture. The solid product formed in each case was fi ltered off and crystallized from ethanol to give 8a-c, respectively (Table I) . (9) . -Equimolar amounts of 8a (3.04 g, 0.01 mol) and malonic acid diethyl ester (1.60 g, , 0.50 mL) and the crude product was precipitated, collected by fi ltration and crystallized from 1,4-dioxane to give 10a and 10b, respectively (Table I) .
2-Ethyl
Ethyl 5-(3-ethoxy-3-oxopropanamido)-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxyl- ate
Ethyl 5-acetamido-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxylate (11)
. -A solution of 8a (3.04 g, 0.01 mol) in acetic acid/acetic anhydride (10:3 mL) was heated under refl ux for 3 hours. The solid product formed upon pouring into an ice/water mixture was collected by fi ltration, washed with water and crystallized from ethanol to give 11 (Table I) . (12) . -A solution of 8a (3.04 g, 0.01 mol) containing a catalytic amount of piperidine (0.50 mL) and benzaldehyde (1.06 g, 0.01 mol) was heated in an oil bath at 120 °C for about 2 hours and then boiled in ethanol (20 mL) for a few minutes. The solid product obtained upon pouring into an acidifi ed ice/water mixture was crystallized from ethanol to give 12 (Table I ).
Ethyl 5-amino-4-(phenylcarbamoyl)-3-styrylthiophene-2-carboxylate

In vitro cytotoxic activity of the newly synthesized compounds
Fetal bovine serum (FBS) and L-glutamine were obtained from Gibco Invitrogen Company (UK). RPMI-1640 medium was provided by Cambrex (USA). Dimethyl sulfoxide (DMSO), doxorubicin, penicillin, streptomycin and sulforhodamine B (SRB) were obtained from Sigma Chemical Company (USA).
Stock solutions of compounds 1 to 12 were pre pared in DMSO and kept at −20 °C. Appropriate dilutions of the compounds were freshly prepared just prior to assays. Final concentrations of DMSO did not interfere with cell growth.
Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), and SF-268 (CNS cancer), were used. MCF-7 was obtained from the European Collection of Cell Cultures (ECACC, Salisbury, UK) and NCI-H460 and SF-268 were kindly provided by the National Cancer Institute (NCI, Cairo, Egypt). They grew as monolayers and were routinely maintained in RPMI-1640 medium supplemented with 5 % heat--inactivated FBS, 2 mmol L -1 glutamine and antibiotics (penicillin 100 g mL -1 , streptomycin 100 μg mL for NCI-H460, followed by 24 h of incubation. The eff ect of the vehicle solvent (DMSO) on the growth of these cell lines was evaluated in all the experiments by exposing untreated control cells to the maximum concentration (0.5 %) of DMSO used in each assay and the results are given in Table III . a Drug concentration required to inhibit tumor cell proliferation by 50 % aft er continuous exposure of 48 h; data are expressed as mean ± SEM of three independent experiments performed in duplicates.
RESULTS AND DISCUSSION
Chemistry
In the present work, we are demonstrating the synthesis of thiophene derivatives together with their cytotoxic evaluation, in continuation of our interest in the design of bioactive heterocycles (23) (24) (25) (26) (27) . Thus, the reaction of ethyl acetoacetate with elemental sulphur and either malononitrile or ethyl cyanoacetate gave the thiophene derivatives 1a,b, respectively. The structures of the products were based on analytical and spectral data. Thus, the 1 H NMR spectrum of 1a showed a singlet at d1.18 ppm for the CH 3 group, a triplet at d1.23 ppm and a quartet at d4.15-4.18 ppm indicating ethoxy group and a singlet atd 7.93 ppm (D 2 O exchangeable) equivalent to the NH 2 group. The 2-amino group present in compound 1a was capable of acetylation. Thus, compound 1a reacted with acetic anhydride to give the N-acetyl derivative 2.
On the other hand, the methyl group, which is in the ortho-position to the cyano group present in compound 1a, showed interesting reactivity towards some reagents. Thus, compound 1a reacted with either benzene-diazonium chloride, 4-chlorobenzene, 4-methoxybenzene or 4-methylbenzene diazonium chloride to give the arylhydrazone derivatives 3a-d, respectively.
Next, we studied the reaction of the thiophene derivative 1a with each ethyl orthoformate and malononitrile. The reaction was carried out in a catalytic amount of piperidine to aff ord the N-methinomalononitrile derivative 4 (Scheme 1). The structure of compound 4 was based on analytical and spectral data. Thus, the 1 H NMR spectrum showed a singlet at d1.63 ppm corresponding to the CH 3 group, a triplet atd 1.30 ppm equivalent to the ester CH 3 group, a quartet at d4.17 ppm for the ester CH 2 group and two singlets at d4.00 and d6.80 ppm for the two CH groups.
Compound 1a reacted with either benzaldehyde, 4-chlorobenzaldehyde or 4-methoxybenzaldehyde to give the benzal derivatives 5a-c, respectively. Similarly, the reaction of 1a with salicyladehyde gave the o-hydroxybenzal derivative 6. The analytical and spectral data of compounds 5a-c and 6 were consistent with their respective structures. On the other hand, the reaction of 1b with malononitrile gave ethyl 3,6-diamino-5-cyano-4-hydroxybenzo[c]thiophen-1-carboxylate 7 (Scheme 2). The analytical and spectral data of the latt er product were the tools of its structural elucidation. Thus, the The 2-amino group present in 8a was capable of amide formation; thus, the reaction of 8a with diethylmalonate gave the (3-ethoxy-3-oxopropanamido)thiophene derivative 9. On the other hand, the reaction of 8a with either malononitrile or ethyl cyanoacetate in refl uxing 1,4-dioxane containing a catalytic amount of triethylamine gave the benzo[c] thiophene derivatives 10a and 10b, respectively. The 1 H NMR and 13 C NMR spectra were the basis of their structure elucidation. The reaction of compound 8a with acetic anhydride gave the N-acetyl derivative 11.
Moreover, the reaction of compound 8a with benzaldehyde gave the benzalidene derivative 12 (Scheme 3). The structure of compound 12 was based on analytical and spectral data. Thus, the 1 H NMR spectrum showed a triplet for the ester CH 3 
In vitro cytotoxic activity of the newly synthesized compounds
The tumor cell growth inhibition activities of the newly synthesized thiophene systems (21 compounds in total) were assessed in vitro (28, 29) on three human tumor cell lines, namely, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), SF-268 (CNS cancer), and normal fi broblast cells (WI-38), aft er continuous exposure for 48 h. The results were compared to the anti-proliferative eff ects of the reference control doxorubicin Scheme 1 Scheme 2 (30) . All compounds were dissolved in DMSO with the maximum concentration 0.5 % in each assay.
The ± SEM means of three independent experiments performed in duplicate.
The results from Table III indicate that most of the compounds demonstrated substantial growth inhibitory eff ects against the human tumor cells at the concentrations tested. The anti-proliferative activity of the test compounds against each of the title tumor cell lines may be arranged in a descending according to the measured concentration required to inhibit tumor cell proliferation by 50 %. Table III that compounds 5b, 8c and 9 showed signifi cant activity against the three tumor cell lines tested. The inhibitory eff ects of other compounds varied, depending on the tested tumor cell, from high to medium or marginal eff ects. Some compounds had no impact on a specifi c tumor cell proliferation, but exhibited some specifi city to another.
It is clear from
Structure activity relationship
It is obvious that compounds 5b, 8c and 9 exhibited maximal cytotoxic eff ect against cancer cell lines, with IC 50 's in the μmol L -1 range. Comparing the cytotoxicity of thiophene derivatives 1a and 1b, it is clear that the cytotoxicity of 1b is higher than that of 1b. The presence of the ethoxy group is responsible for the higher potency of 1b. Acetylation of Scheme 3 compound 1a gave the N-acetyl derivative 2, for which the cytotoxicity apparently increased. As regards the arylhydrazone derivatives 3a-d, it is clear that the unsubstituted aryl derivatives showed the highest cytotoxicity among the four compounds. On the other hand, the reaction of compound 1a with malononitrile and ethyl orthoformate to give compound 4 resulted in a remarkable decrease of cyctotoxicity. Moreover, it is obvious for the benzalthiophene derivatives 5a-c that compound 5b showed high cytotoxicity due to the presence of the chloro group. The reaction of 1a with either salicylaldehyde or malononitrile gave compound 6 or 7, respectively, which showed a moderate increase in their cytotoxicity. On the other hand, it is clear for the other series of the thiophene amide derivatives 8a, 8b and 8c that the presence of the OCH 3 group in compound 8c is responsible for higher cytotoxicity than that of compound 8b, which bears the CH 3 group. Moreover, compound 9 revealed higher cytotoxicity than doxorubicin; such high cytotoxicity was att ributed to the presence of two ethoxy groups. It is clear from Table III that the thiophene derivatives 10a, 10b and 11 showed moderate cytotoxicity. It is noteworthy that the reaction of compound 8a with benzaldehyde to give benzylidine derivative 12 resulted in remarkable increase in cytotoxicity. Our results showed that, in most cases, the electronegative Cl, OCH 3 and OC 2 H 5 hydrophobic groups in the thiophene derivatives might play a very important role in enhancing the cytotoxic eff ect. It is clear from Table III that compounds 1a, 4 and 6 showed cytotoxicity against the normal cell line WI-38 and low potency against the cancer cell lines.
CONCLUSIONS
In summary, we have developed a convenient synthetic approach for novel thiophene and benzothiophene derivatives. The region selective att ack by diff erent reagents on the active center moiety in the thiophene system led to the diversity of the produced systems. Most of the newly synthesized compounds were found to be promising anti-proliferative agents. Results showed that ethyl 5-amino-3-(4-chlorostyryl)-4-cyanothiophene-2-carboxylate (5b), ethyl 5-amino-4-[(4-methoxyphenyl)carbamoyl]-3-methylthiophene-2-carboxylate (8c) and ethyl 5-(3-ethoxy-3-oxopropanamido)-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxylate (9) are the most active compounds against the three tumor cell lines such as MCF-7, NCI-H460 and SF-268. At the same time, they showed low potency against the normal fi broblasts human cell line (WI-38). On the other hand, compounds 1a, 4 and 6, although showing low potency against the cancer cell lines, showed high potency against the normal fi broblasts (WI-38) cell lines.
